Baseline Demographic and Clinical Characteristics for 70 Youth With Human Immunodeficiency Virus
Characteristic . | Participants, No. (%)a . |
---|---|
Demographic | |
ȃAge at study enrollment, mean (SD) [IQR], y | 24.4 (0.5) [24.0–25.0] |
ȃSex | |
ȃȃMale | 62 (88.6) |
ȃȃFemale | 8 (11.4) |
ȃRace/ethnicity | |
ȃȃBlack/African-American | 65 (92.9) |
ȃȃHispanic/Latino/Latina | 1 (1.4) |
ȃȃWhite | 3 (4.3) |
ȃȃOther | 4 (5.7) |
ȃMode of acquisition | |
ȃȃHorizontal | 58 (82.9) |
ȃȃVertical | 12 (17.1) |
ȃSexual orientation | |
ȃȃStraight/heterosexual | 13 (18.6) |
ȃȃGay/queer/bisexual/questioning | 57 (81.4) |
ȃHighest educational level | |
ȃȃLess than high school diploma | 9 (12.9) |
ȃȃHigh school diploma | 18 (25.7) |
ȃȃSome college or technical school | 25 (35.7) |
ȃȃTechnical school graduate | 5 (7.1) |
ȃȃCollege graduate | 13 (18.6) |
ȃEmployment | |
ȃȃUnemployed | 20 (28.6) |
ȃȃEmployed full time | 28 (40.0) |
ȃȃEmployed part time | 22 (31.4) |
ȃHousehold income | |
ȃȃ<$10 000 | 28 (40.0) |
ȃȃ$10 000–$19 999 | 19 (27.1) |
ȃȃ$20 000–$29 999 | 12 (17.1) |
ȃȃ≥$30 000 | 11 (15.7) |
Clinical | |
ȃCD4+ T-cell count, mean (SD) [IQR], cells/μL | 494.4 (278.3) [8.0–1202] |
ȃHIV RNA suppressed (<200 copies/mL) | 52 (74.3) |
ȃSTI (gonorrhea, chlamydia, or syphilis) in last 12 mo | 42 (60.0) |
ȃComorbid conditions | |
ȃȃHypertension | 4 (5.7) |
ȃȃAsthma | 10 (14.3) |
ȃȃDepression | 22 (31.4) |
ȃȃAnxiety | 10 (14.3) |
ȃAny documented history of opportunistic infection | 9 (12.9) |
Characteristic . | Participants, No. (%)a . |
---|---|
Demographic | |
ȃAge at study enrollment, mean (SD) [IQR], y | 24.4 (0.5) [24.0–25.0] |
ȃSex | |
ȃȃMale | 62 (88.6) |
ȃȃFemale | 8 (11.4) |
ȃRace/ethnicity | |
ȃȃBlack/African-American | 65 (92.9) |
ȃȃHispanic/Latino/Latina | 1 (1.4) |
ȃȃWhite | 3 (4.3) |
ȃȃOther | 4 (5.7) |
ȃMode of acquisition | |
ȃȃHorizontal | 58 (82.9) |
ȃȃVertical | 12 (17.1) |
ȃSexual orientation | |
ȃȃStraight/heterosexual | 13 (18.6) |
ȃȃGay/queer/bisexual/questioning | 57 (81.4) |
ȃHighest educational level | |
ȃȃLess than high school diploma | 9 (12.9) |
ȃȃHigh school diploma | 18 (25.7) |
ȃȃSome college or technical school | 25 (35.7) |
ȃȃTechnical school graduate | 5 (7.1) |
ȃȃCollege graduate | 13 (18.6) |
ȃEmployment | |
ȃȃUnemployed | 20 (28.6) |
ȃȃEmployed full time | 28 (40.0) |
ȃȃEmployed part time | 22 (31.4) |
ȃHousehold income | |
ȃȃ<$10 000 | 28 (40.0) |
ȃȃ$10 000–$19 999 | 19 (27.1) |
ȃȃ$20 000–$29 999 | 12 (17.1) |
ȃȃ≥$30 000 | 11 (15.7) |
Clinical | |
ȃCD4+ T-cell count, mean (SD) [IQR], cells/μL | 494.4 (278.3) [8.0–1202] |
ȃHIV RNA suppressed (<200 copies/mL) | 52 (74.3) |
ȃSTI (gonorrhea, chlamydia, or syphilis) in last 12 mo | 42 (60.0) |
ȃComorbid conditions | |
ȃȃHypertension | 4 (5.7) |
ȃȃAsthma | 10 (14.3) |
ȃȃDepression | 22 (31.4) |
ȃȃAnxiety | 10 (14.3) |
ȃAny documented history of opportunistic infection | 9 (12.9) |
Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range; SD, standard deviation; STI, sexually transmitted infection.
Data represent no. (%) of participants unless otherwise specified.
Baseline Demographic and Clinical Characteristics for 70 Youth With Human Immunodeficiency Virus
Characteristic . | Participants, No. (%)a . |
---|---|
Demographic | |
ȃAge at study enrollment, mean (SD) [IQR], y | 24.4 (0.5) [24.0–25.0] |
ȃSex | |
ȃȃMale | 62 (88.6) |
ȃȃFemale | 8 (11.4) |
ȃRace/ethnicity | |
ȃȃBlack/African-American | 65 (92.9) |
ȃȃHispanic/Latino/Latina | 1 (1.4) |
ȃȃWhite | 3 (4.3) |
ȃȃOther | 4 (5.7) |
ȃMode of acquisition | |
ȃȃHorizontal | 58 (82.9) |
ȃȃVertical | 12 (17.1) |
ȃSexual orientation | |
ȃȃStraight/heterosexual | 13 (18.6) |
ȃȃGay/queer/bisexual/questioning | 57 (81.4) |
ȃHighest educational level | |
ȃȃLess than high school diploma | 9 (12.9) |
ȃȃHigh school diploma | 18 (25.7) |
ȃȃSome college or technical school | 25 (35.7) |
ȃȃTechnical school graduate | 5 (7.1) |
ȃȃCollege graduate | 13 (18.6) |
ȃEmployment | |
ȃȃUnemployed | 20 (28.6) |
ȃȃEmployed full time | 28 (40.0) |
ȃȃEmployed part time | 22 (31.4) |
ȃHousehold income | |
ȃȃ<$10 000 | 28 (40.0) |
ȃȃ$10 000–$19 999 | 19 (27.1) |
ȃȃ$20 000–$29 999 | 12 (17.1) |
ȃȃ≥$30 000 | 11 (15.7) |
Clinical | |
ȃCD4+ T-cell count, mean (SD) [IQR], cells/μL | 494.4 (278.3) [8.0–1202] |
ȃHIV RNA suppressed (<200 copies/mL) | 52 (74.3) |
ȃSTI (gonorrhea, chlamydia, or syphilis) in last 12 mo | 42 (60.0) |
ȃComorbid conditions | |
ȃȃHypertension | 4 (5.7) |
ȃȃAsthma | 10 (14.3) |
ȃȃDepression | 22 (31.4) |
ȃȃAnxiety | 10 (14.3) |
ȃAny documented history of opportunistic infection | 9 (12.9) |
Characteristic . | Participants, No. (%)a . |
---|---|
Demographic | |
ȃAge at study enrollment, mean (SD) [IQR], y | 24.4 (0.5) [24.0–25.0] |
ȃSex | |
ȃȃMale | 62 (88.6) |
ȃȃFemale | 8 (11.4) |
ȃRace/ethnicity | |
ȃȃBlack/African-American | 65 (92.9) |
ȃȃHispanic/Latino/Latina | 1 (1.4) |
ȃȃWhite | 3 (4.3) |
ȃȃOther | 4 (5.7) |
ȃMode of acquisition | |
ȃȃHorizontal | 58 (82.9) |
ȃȃVertical | 12 (17.1) |
ȃSexual orientation | |
ȃȃStraight/heterosexual | 13 (18.6) |
ȃȃGay/queer/bisexual/questioning | 57 (81.4) |
ȃHighest educational level | |
ȃȃLess than high school diploma | 9 (12.9) |
ȃȃHigh school diploma | 18 (25.7) |
ȃȃSome college or technical school | 25 (35.7) |
ȃȃTechnical school graduate | 5 (7.1) |
ȃȃCollege graduate | 13 (18.6) |
ȃEmployment | |
ȃȃUnemployed | 20 (28.6) |
ȃȃEmployed full time | 28 (40.0) |
ȃȃEmployed part time | 22 (31.4) |
ȃHousehold income | |
ȃȃ<$10 000 | 28 (40.0) |
ȃȃ$10 000–$19 999 | 19 (27.1) |
ȃȃ$20 000–$29 999 | 12 (17.1) |
ȃȃ≥$30 000 | 11 (15.7) |
Clinical | |
ȃCD4+ T-cell count, mean (SD) [IQR], cells/μL | 494.4 (278.3) [8.0–1202] |
ȃHIV RNA suppressed (<200 copies/mL) | 52 (74.3) |
ȃSTI (gonorrhea, chlamydia, or syphilis) in last 12 mo | 42 (60.0) |
ȃComorbid conditions | |
ȃȃHypertension | 4 (5.7) |
ȃȃAsthma | 10 (14.3) |
ȃȃDepression | 22 (31.4) |
ȃȃAnxiety | 10 (14.3) |
ȃAny documented history of opportunistic infection | 9 (12.9) |
Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range; SD, standard deviation; STI, sexually transmitted infection.
Data represent no. (%) of participants unless otherwise specified.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.